Total Payments
$17,372
2024 Payments
$1,050
Companies
54
Transactions
827
Medicare Patients
1,467
Medicare Billing
$138,830
Payment Breakdown by Category
Food & Beverage$17,182 (98.9%)
Education$189.29 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,182 | 815 | 98.9% |
| Education | $189.29 | 12 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,442 | 141 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,061 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,847 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,543 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,027 | 67 | $0 (2024) |
| Lilly USA, LLC | $739.45 | 43 | $0 (2024) |
| Amgen Inc. | $650.02 | 20 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $634.06 | 23 | $0 (2022) |
| ABBVIE INC. | $548.90 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $485.68 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,050 | 36 | AstraZeneca Pharmaceuticals LP ($336.25) |
| 2023 | $1,423 | 67 | GlaxoSmithKline, LLC. ($238.22) |
| 2022 | $1,505 | 64 | AstraZeneca Pharmaceuticals LP ($370.41) |
| 2021 | $1,763 | 81 | Novo Nordisk Inc ($302.71) |
| 2020 | $1,809 | 97 | Novo Nordisk Inc ($404.59) |
| 2019 | $2,970 | 139 | Novo Nordisk Inc ($351.97) |
| 2018 | $3,312 | 164 | Novo Nordisk Inc ($671.56) |
| 2017 | $3,539 | 179 | Novo Nordisk Inc ($529.45) |
All Payment Transactions
827 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | RGH Enterprises LLC | — | Food and Beverage | In-kind items and services | $17.93 | General |
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: Oncology | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: UROLOGY | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Insomnia | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 265 | 367 | $62,643 | $30,407 |
| 2022 | 10 | 403 | 542 | $83,649 | $38,771 |
| 2021 | 9 | 351 | 461 | $71,446 | $35,896 |
| 2020 | 14 | 448 | 592 | $61,076 | $33,757 |
Total Patients
1,467
Total Services
1,962
Medicare Billing
$138,830
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 129 | $26,058 | $11,223 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 118 | $16,756 | $7,950 | 47.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 13 | $4,550 | $2,940 | 64.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $5,922 | $2,616 | 44.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 32 | $4,544 | $2,278 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,678 | $1,715 | 64.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 14 | $1,260 | $1,165 | 92.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $420.00 | $268.80 | 64.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $455.00 | $249.60 | 54.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 168 | $33,936 | $14,795 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 125 | $17,750 | $7,328 | 41.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 59 | 81 | $11,502 | $5,336 | 46.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 32 | $9,024 | $3,440 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $5,150 | $3,379 | 65.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 31 | 31 | $2,790 | $2,577 | 92.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 31 | 31 | $930.00 | $609.37 | 65.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 14 | $1,232 | $504.64 | 41.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 24 | 24 | $840.00 | $461.91 | 55.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $495.00 | $338.55 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 137 | $27,674 | $13,213 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 108 | $15,294 | $7,110 | 46.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 58 | 83 | $11,534 | $5,481 | 47.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 27 | $7,614 | $3,705 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $3,914 | $2,616 | 66.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 24 | 24 | $2,160 | $2,072 | 95.9% |
About Dr. Bernard Bacay, MD
Dr. Bernard Bacay, MD is a Internal Medicine healthcare provider based in Manteca, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629094032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Bacay, MD has received a total of $17,372 in payments from pharmaceutical and medical device companies, with $1,050 received in 2024. These payments were reported across 827 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($17,182).
As a Medicare-enrolled provider, Bacay has provided services to 1,467 Medicare beneficiaries, totaling 1,962 services with total Medicare billing of $138,830. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Manteca, CA
- Active Since 07/15/2006
- Last Updated 01/02/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629094032
Products in Payments
- FARXIGA (Drug) $1,549
- XARELTO (Drug) $1,427
- Ozempic (Drug) $1,111
- JARDIANCE (Drug) $944.05
- Victoza (Drug) $689.26
- TRELEGY ELLIPTA (Drug) $584.57
- ENTRESTO (Drug) $485.68
- Vascepa (Drug) $476.89
- Kerendia (Drug) $463.63
- VRAYLAR (Drug) $461.74
- ELIQUIS (Drug) $459.72
- INVOKANA (Drug) $414.60
- Livalo (Drug) $385.71
- TRULICITY (Drug) $314.36
- Tresiba (Drug) $308.20
- REXULTI (Drug) $272.73
- JANUVIA (Drug) $268.68
- Repatha (Biological) $244.05
- SOLIQUA (Drug) $213.41
- QUVIVIQ (Drug) $185.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manteca
Anupam Chahal, Md, MD
Internal Medicine — Payments: $50,729
Internal Medicine $50,729
Maria Bacay, Md, MD
Internal Medicine — Payments: $19,811
Internal Medicine $19,811
Dr. Abdul Khan, M.d, M.D
Internal Medicine — Payments: $18,150
Internal Medicine $18,150
Dr. Anil Sain, Md, MD
Internal Medicine — Payments: $17,533
Internal Medicine $17,533
Dr. Rahul Patel, M.d, M.D
Internal Medicine — Payments: $16,024
Internal Medicine $16,024
Dr. Glenmore Lasam, M.d, M.D
Internal Medicine — Payments: $8,893
Internal Medicine $8,893